Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

DPHARMA DUOPHARMA BIOTECH BERHAD
Quotes 15 Minutes Delayed. Updated at 14 Aug 2020 16:59
Last (MYR): 2.920 Change: -0.230 High: 3.150 Remarks:
Change (%): -7.30 Low: 2.880
Open 3.150 Yesterday's Close 3.150
Buy Price 2.920 Sell Price 2.930
Buy Volume ('00) 424 Sell Volume ('00) 283
Cumulative Volume ('00) 197,148 Cumulative Value 58,502,758
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.07829 Trailing EPS (MYR) e 0.07701 NAV (MYR) b 0.7663
PE a 37.297 Trailing PE f 37.919 Price / NAV b 3.8105
Dividend (MYR) d 0.058161 Cash In Hand (MYR) g 0.1795 Issued & Paid-up Shares c 706,027,000
Dividend Yield (%) d 1.992 Price / Cash In Hand g 16.267 Treasury Shares h -
Beta - 75 Daysi -0.126 R-Squared - 75 Days(%)i 0.76 Market Cap (M) 2,061.599
Beta - 500 Daysi 0.780 R-Squared - 500 Days (%)i 5.58 Enterprise Value (M) 2,210.717
Piotroski F Score 4 Exchange Code 7148 Par Value ( MYR ) n.a.
52 Weeks Volatility (%) 47.17 6-Month VWAP 2.717 Free Float (%) 40.9
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Biotechnology
Index Components BM HEALTH CARE
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Aug 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference DPHARMA Bursa 2,061.599 37.297 37.919 3.8105 1.992
Industry Biotechnology Bursa 2,061.599 37.298 37.919 3.8104 1.992
PHARMACEUTICALS Bursa 598.836 373.121 205.551 3.0868 1.712
Index BM HEALTH CARE Bursa 13,053.916 98.869 94.048 6.2407 0.484
Global Peer AMGEN INC NASDAQ 140,396.709 17.903 19.235 13.1717 2.443
Global Peer CSL ASX 126,834.048 47.275 43.784 14.6656 0.950
Global Peer GILEAD SCIENCES INC NASDAQ 85,879.820 15.945 - 4.7640 3.715
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,620.224 59.160 33.459 9.2589 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,172.529 30.803 21.844 7.1955 -
Global Peer ILLUMINA INC NASDAQ 50,743.760 50.643 73.223 11.1207 -
Global Peer BIOGEN INC NASDAQ 45,823.698 7.782 7.732 4.0521 -
Global Peer WUXI BIO HKEx 216,907.105 188.686 188.685 15.1677 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,364.508 - - 15.0845 -
Other Global Peers MODERNA INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), Lonza (SGX), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), SORRENTO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ALKERMES PLC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VAXCYTE INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALLOVIR INC (NASDAQ), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), VIELA BIO INC (NASDAQ), MESOBLAST LTD (ASX), ALPHAMAB-B (HKEx), VERACYTE INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MYOVANT SCIENCES LTD (NYSE), ROCKET PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), COMPUGEN (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), ITEOS THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VAXART INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), STOKE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RETROPHIN INC (NASDAQ), NKARTA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), PRECIGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KADMON HLDGS INC (NYSE), AKOUOS INC (NASDAQ), AGENUS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), IMMATICS N V (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), UROGEN PHARMA LTD (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ARDELYX INC (NASDAQ), XBIOTECH INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ATHERSYS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), KAMADA (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), IVERIC BIO INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ESSEX BIO-TECH (HKEx), MANNKIND CORPORATION (NASDAQ), NANOVIRICIDES INC (NYSE American), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), TREVENA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), PFENEX INC (NYSE American), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NEXTCURE INC (NASDAQ), VERASTEM INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), IBIO INC (NYSE American), CASI PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), XOMA CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NEXT SCIENCE LTD (ASX), CHIMERIX INC (NASDAQ), IMUGENE LIMITED (ASX), GLYCOMIMETICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CONTRAFECT CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EQUILLIUM INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), VACCINEX INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), SIERRA ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ARAVIVE INC (NASDAQ), SAVARA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), SYNLOGIC INC (NASDAQ), RESTORBIO INC (NASDAQ), MEMPHASYS LTD (ASX), GENOCEA BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), OCUGEN INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), RECRO PHARMA INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), COHBAR INC (NASDAQ), ANTEOTECH LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD (ASX), MONOPAR THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), GENETIC TECHNOLOGIES (ASX), MICROBOT MEDICAL INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), SUNESIS PHARMACEUTICALS INC (NASDAQ), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CT ENTERPRISE (HKEx), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORAGENICS INC (NYSE American), BIONOMICS LTD (ASX), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AIKIDO PHARMA INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), ALIMERA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), REGENEUS LTD (ASX), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), Suntar Eco-City (SGX), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), RHINOMED LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), PATRYS LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), SENESTECH INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), HAO WEN HLDGS (HKEx), AURIS MEDICAL HOLDING LTD (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.040
+1.39 %
10 Days -+0.290
+11.03 %
20 Days -+1.010
+52.88 %
Medium Term Return 3 Months 0.050+1.240
+76.79 %
6 Months 0.050+1.280
+81.10 %
1 Year 0.060+1.590
+124.06 %
Long Term Return 2 Years 0.115+1.660
+140.87 %
3 Years 0.200+2.067
+265.77 %
5 Years 0.360+1.870
+212.38 %
Annualised Return Annualised --
+25.58 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.050 - 3.670 Change From 1 Year Low +1.870 % Change From 1 Year Low (%) +178.10
Change From 1 Year High -0.750 % Change From 1 Year High (%) -20.44
2 Years Range 0.925 - 3.670 Change From 2 Years Low +1.995 % Change From 2 Years Low (%) +215.68
Change From 2 Years High -0.750 % Change From 2 Years High (%) -20.44
5 Years Range 0.814 - 3.670 Change From 5 Years Low +2.106 % Change From 5 Years Low (%) +258.59
Change From 5 Years High -0.750 % Change From 5 Years High (%) -20.44
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CCM Duopharma Biotech Berhad, an investment holding company, engages in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the counter products, including analgesic/anti-pyretics, antibacterial mouthwash, childrens vitamins, cough preparations, dermatology products, eye drops, first aid dressings, and health suppliments. The company provides its products in various forms, such as tablets, capsules, syrup, oral antibiotic, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges, and eye drop preparations. It exports its products to various countries, including Vietnam, Ethiopia, Sudan, South East Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. The company was founded in 1979 and is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

IPO Performance

Listing Date 18 Jul 2002 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 7.50 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.100 First Day Close (MYR) 1.043 First Week Close (MYR) 1.006
Current vs IPO Price (%) +39.05 First Day Gain (%) -50.33 First Week Gain (%) -52.10

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(2.89 MB)
Part 2(2.98 MB)
Annual Report 2018 Dec 2018 Part 1(2.61 MB)
Part 2(2.17 MB)
Annual Report 2018 Apr 2018 Part 1(1.46 MB)
Part 2(0.88 MB)
Part 3(0.27 MB)
Part 4(2.43 MB)
Part 5(1.63 MB)
Annual Report 2016 Dec 2016 Part 1(2.85 MB)
Part 2(0.73 MB)
Annual Report 2015 Dec 2015 Part 1(0.08 MB)
Part 2(2.44 MB)
Part 3(0.02 MB)
Part 4(0.04 MB)
Annual Report 2014 Dec 2014 Part 1(2.20 MB)
Annual Report 2013 Dec 2013 Part 1(1.34 MB)
Annual Report 2012 Dec 2012 Part 1(1.64 MB)
Annual Report 2011 Dec 2011 Part 1(1.12 MB)
Part 2(0.11 MB)
Annual Report 2010 Dec 2010 Part 1(2.37 MB)
Annual Report 2009 Dec 2009 Part 1(2.87 MB)
Part 2(0.15 MB)
Annual Report 2008 Dec 2008 Part 1(0.82 MB)
Annual Report 2007 Dec 2007 Part 1(0.04 MB)
Part 2(2.16 MB)
Annual Report 2006 Dec 2006 Part 1(1.01 MB)
Part 2(0.02 MB)
Annual Report 2005 Dec 2005 Part 1(0.30 MB)
Part 2(0.82 MB)
Annual Report 2004 Dec 2004 Part 1(0.52 MB)
Part 2(1.35 MB)
Annual Report 2003 Dec 2003 Part 1(0.63 MB)
Annual Report 2002 Dec 2002 Part 1(1.12 MB)
Part 2(0.42 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
14 Aug 2020 3.150 3.150 2.880 2.920 19,714,800 2.9667
13 Aug 2020 3.310 3.310 3.130 3.150 13,617,300 3.2054
12 Aug 2020 3.290 3.550 3.100 3.290 77,498,400 3.3305
11 Aug 2020 3.190 3.290 2.960 3.130 17,999,400 3.1164
10 Aug 2020 3.120 3.400 2.920 3.170 58,844,900 3.2111
07 Aug 2020 3.130 3.150 2.870 2.880 15,465,300 2.9916
06 Aug 2020 3.250 3.300 3.010 3.080 23,351,700 3.1204
05 Aug 2020 2.850 3.380 2.760 3.190 69,264,100 3.0974
04 Aug 2020 2.750 2.890 2.660 2.790 20,516,400 2.7722
03 Aug 2020 2.690 2.780 2.630 2.710 18,204,900 2.7095
30 Jul 2020 2.700 2.800 2.610 2.630 18,360,500 2.7111
29 Jul 2020 2.820 2.840 2.610 2.690 24,464,100 2.7041
28 Jul 2020 2.960 2.960 2.790 2.820 15,697,000 2.8450
27 Jul 2020 2.650 2.940 2.620 2.870 49,534,000 2.8254
24 Jul 2020 2.820 2.930 2.580 2.620 39,564,300 2.7038
23 Jul 2020 3.260 3.670 2.810 2.850 113,439,300 3.2590
22 Jul 2020 2.350 2.960 2.350 2.960 104,802,100 2.8618
21 Jul 2020 1.910 2.400 1.900 2.280 72,275,100 2.2362
20 Jul 2020 1.950 1.960 1.860 1.900 4,445,500 1.9004
17 Jul 2020 1.970 2.010 1.900 1.910 7,010,200 1.9404
16 Jul 2020 1.970 2.090 1.920 1.950 16,854,900 2.0039
15 Jul 2020 2.110 2.110 1.800 1.890 21,374,300 1.9016
Summary
Current 2 Weeks
(03 Aug 2020 to 14 Aug 2020)
2.690 3.550 2.630 2.920 334,477,200 -
Previous 2 Weeks
(17 Jul 2020 to 30 Jul 2020)
1.970 3.550 1.900 2.630 449,592,100 -
4 Weeks from
(19 Jun 2020 to 16 Jul 2020)
1.710 3.550 1.670 1.950 53,730,500 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.